Patents by Inventor Stefan Peters

Stefan Peters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170266160
    Abstract: This invention relates to 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides of formula 1 and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases connected with dipeptidyl peptidase I activity, e.g. respiratory diseases.
    Type: Application
    Filed: June 6, 2017
    Publication date: September 21, 2017
    Inventors: Ralf ANDERSKEWITZ, Florian BINDER, Matthias GRAUERT, Marc GRUNDL, Peter Wilhelm HAEBEL, Thorsten OOST, Alexander PAUTSCH, Stefan PETERS, Viktor VINTONYAK
  • Publication number: 20170271621
    Abstract: The present invention relates to a current-light conversion device (1), such as an OLED or an OPVD, wherein the current-light conversion device comprises a substrate (10), a current-light conversion arrangement (11) comprising a current-light conversion material (111) provided between a first and a second electrode layer (110, 112), and a barrier layer (12) comprising a transparent organic layer (121) provided between a first and a second transparent inorganic barrier layer (120, 122). A getter material is provided in the transparent organic layer (121) in a pattern of getter dots (1210). Since the getter material is provided in a pattern of getter dots (1210), the light scattering effect resulting from dispersed getter particles can be avoided, resulting in improved transparency characteristics of the barrier layer (12) while still providing the desired getter functionality.
    Type: Application
    Filed: August 17, 2015
    Publication date: September 21, 2017
    Inventors: Herbert LIFKA, Roy Gerardus Franciscus Antonius VERBEEK, Petrus Cornelis Paulus BOUTEN, Peter VAN DE WEIJER, Matheus Godefridus Johannus BEL, Manfred Stephan RUSKE, Rainald Manfred GIERTH, Jens MEYER, Stefan Peter GRABOWSKI, Helga HUMMEL
  • Patent number: 9713606
    Abstract: This invention relates to 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides of formula 1 and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases connected with dipeptidyl peptidase I activity, e.g. respiratory diseases.
    Type: Grant
    Filed: December 1, 2015
    Date of Patent: July 25, 2017
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Ralf Anderskewitz, Florian Binder, Matthias Grauert, Marc Grundl, Peter Wilhelm Haebel, Thorsten Oost, Alexander Pautsch, Stefan Peters, Viktor Vintonyak
  • Patent number: 9670166
    Abstract: This invention relates to substituted bicyclic dihydropyrimidinones of formula 1 and their use as inhibitors of neutrophil elastase activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of pulmonary, gastrointestinal and genitourinary diseases, inflammatory diseases of the skin and the eye and other autoimmune and allergic disorders, allograft rejection, and oncological diseases.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: June 6, 2017
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Christian Gnamm, Thorsten Oost, Stefan Peters, Holger Hoesch, Uwe Joerg Ries
  • Patent number: 9663470
    Abstract: The present invention relates to compounds defined by formula I wherein the variables R1, R2, R3, R4, and m are defined as in claim 1, possessing valuable pharmacological activity. Particularly, the compounds are inhibitors of 11?-hydroxysteroid dehydrogenase (HSD) 1 and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme, such as metabolic diseases, in particular diabetes type 2, obesity, and dyslipidemia.
    Type: Grant
    Filed: March 24, 2016
    Date of Patent: May 30, 2017
    Assignees: Vitae Pharmaceuticals, Inc., Boehringer Ingelheim International Gmbh
    Inventors: Matthias Eckhardt, Frank Himmelsbach, Linghang Zhuang, Stefan Peters, Herbert Nar
  • Patent number: 9657015
    Abstract: Substituted bicyclic dihydropyrimidinones of formula 1 which are inhibitors of neutrophil elastase activity and useful as medicaments for the treatment of, inter alia, COPD.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: May 23, 2017
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Christian Gnamm, Ralf Anderskewitz, Holger Hoesch, Gerd Morschhaeuser, Thorsten Oost, Stefan Peters, Uwe Joerg Ries
  • Publication number: 20170122831
    Abstract: A system for project planning for an engine for determining an operating behavior of the engine to be expected under defined operating conditions of the engine includes: a plurality of sensors configured to measure respective ones of the defined operating conditions of the engine; and a knocking intensity prediction tool configured to determine the knocking intensity of the engine to be expected under the defined operating conditions of the engine.
    Type: Application
    Filed: October 28, 2016
    Publication date: May 4, 2017
    Inventors: Stefan Peters, Matthias Bachmann, Sebastian Blasberg
  • Patent number: 9617251
    Abstract: The present invention relates to compounds of general formula I, wherein the groups R, R1, R2, R3, m and n are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.
    Type: Grant
    Filed: August 1, 2016
    Date of Patent: April 11, 2017
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Matthias Eckhardt, Stefan Peters, Holger Wagner
  • Publication number: 20170037040
    Abstract: The present invention relates to compounds of general formula I, wherein the groups R, R1, R2, R3, m and n are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.
    Type: Application
    Filed: August 1, 2016
    Publication date: February 9, 2017
    Inventors: Matthias ECKHARDT, Stefan PETERS, Holger WAGNER
  • Publication number: 20160365530
    Abstract: The invention relates to OLEDs (1) having a substrate (2), a first electrode layer (3), a layer of organic electroluminescence material (4), a second electrode layer (5), a cover layer (6), moisture-absorbing means (9) and a separating foil (10) of resilient material. According to the invention, said foil (10) is positioned between the second electrode layer (5) and the moisture-absorbing means (9). This feature results in a longer mean life-time of the OLED. Advantageously spacer structures (12) (preferably formed as dots) are applied on the separating foil (10) between the foil (10) and the cover (6). This prevents discoloring effects around the rim of the OLED material.
    Type: Application
    Filed: July 5, 2016
    Publication date: December 15, 2016
    Inventors: Herbert Friedrich Boerner, Rainald Manfred Gierth, Stefan Peter Grabowski, Petrus Cornelis Paulus Bouten, Peter Van De Weijer
  • Publication number: 20160343988
    Abstract: The present invention relates to an encapsulated semiconductor device (20) provided on a flexible substrate (1), a method of providing an at least partially encapsulated semiconductor device (20) on a flexible substrate (1) and a software product for providing an at least partially encapsulated semiconductor device (20) on a flexible substrate (1). In a preferred embodiment, an encapsulation method is presented in which the organic layer (3) of an inorganic/organic/inorganic multilayer barrier (5) on a plastic foil (1) as a substrate is removed at the edges of an OLED (13). The edges are subsequently sealed with a standard TFE process to encapsulate the OLED (13). This enables cuttable OLEDs (20) that are cut out of a larger plastic substrate (1) and gives a method to reduce side leakage in OLEDs (20) that have been manufactured in a roll-to-toll process.
    Type: Application
    Filed: January 13, 2015
    Publication date: November 24, 2016
    Applicant: OLEDWORKS GMBH
    Inventors: Jens Meyer, Rainald Manfred Gierth, Stefan Peter Grabowski, Herbert Lifka, Peter Van De Weijer, Petrus Cornelis-Paulus Bouten, Volker Lambert Van Elsbergen, Manfred Stephan Ruske, Soren Hartmann
  • Publication number: 20160340319
    Abstract: This invention relates to substituted bicyclic dihydropyrimidinones of formula 1 and their use as inhibitors of neutrophil elastase activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of pulmonary, gastrointestinal and genitourinary diseases, inflammatory diseases of the skin and the eye and other autoimmune and allergic disorders, allograft rejection, and oncological diseases.
    Type: Application
    Filed: August 5, 2016
    Publication date: November 24, 2016
    Inventors: Christian GNAMM, Thorsten OOST, Stefan PETERS, Holger HOESCH, Uwe Joerg RIES
  • Publication number: 20160313163
    Abstract: A method for determining a gas consumption of a gas-powered gas engine or a gas-powered dual-fuel engine. The engine is operated under actual operating conditions, and the actual gas consumption of the engine is acquired under the actual operating conditions. A target gas consumption of the engine to be anticipated under target operating conditions is calculated depending on the actual gas consumption and depending on discrepancies between the actual operating conditions and the target operating conditions.
    Type: Application
    Filed: April 20, 2016
    Publication date: October 27, 2016
    Inventors: Stefan PETERS, Günter HEIDER, Thomas KREMSER
  • Patent number: 9475779
    Abstract: Substituted bicyclic dihydropyrimidinones of formula 1 which are inhibitors of neutrophil elastase and useful as medicaments for the treatment of, inter alia, COPD.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: October 25, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thorsten Oost, Ralf Anderskewitz, Christian Gnamm, Holger Hoesch, Gerd Morschhaeuser, Stefan Peters, Uwe Joerg Ries
  • Patent number: 9458113
    Abstract: Substituted dihydropyrimidinones of formula 1 which are neutrophil elastase inhibitors and useful as medicaments for the treatment of, inter alia, COPD.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: October 4, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Stefan Peters, Ralf Anderskewitz, Christian Gnamm, Holger Hoesch, Gerd Morschhaeuser, Thorsten Oost, Uwe Joerg Ries
  • Publication number: 20160272590
    Abstract: The present invention relates to compounds defined by formula I wherein the variables R1, R2, R3, R4, and m are defined as in claim 1, possessing valuable pharmacological activity. Particularly, the compounds are inhibitors of 11?-hydroxysteroid dehydrogenase (HSD) 1 and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme, such as metabolic diseases, in particular diabetes type 2, obesity, and dyslipidemia.
    Type: Application
    Filed: March 24, 2016
    Publication date: September 22, 2016
    Inventors: Matthias Eckhardt, Frank Himmelsbach, Linghang Zhuang, Stefan Peters, Herbert Nar
  • Patent number: 9440930
    Abstract: Substituted bicyclic dihydropyrimidinones of formula 1 and their use as inhibitors of neutrophil elastase activity.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: September 13, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thorsten Oost, Ralf Anderskewitz, Christian Gnamm, Gerd Morschhaeuser, Stefan Peters, Uwe Joerg Ries
  • Publication number: 20160235376
    Abstract: A patient-supporting device is disclosed. The patient-supporting device includes a fastening assembly that fastens the patient-supporting device to a structural member, a support member configured to receive a body part of a patient, and a height adjustment assembly that adjusts a distance between the fastening assembly and the support member. The height adjustment assembly includes a locking assembly and an elongated member. The support member is attached to a first end portion of the elongated member. The locking assembly is stationary relative to the fastening assembly. The elongated member is guided in an aperture of the locking assembly in a longitudinal direction of the elongated member. A plurality of first snap-in recesses is disposed on a first side portion of the elongated member. The locking assembly includes a first locking member.
    Type: Application
    Filed: April 12, 2016
    Publication date: August 18, 2016
    Applicant: MAQUET GMBH
    Inventors: Jochen KAISER, Ulrich WYSLUCHA, Stefan PETER, Siegfried HUND
  • Patent number: 9392649
    Abstract: An organic electroluminescence device (OLED) has a substrate, a first electrode layer, a layer of organic electroluminescence material, a second electrode layer, a cover layer, a moisture-absorber and a separating foil of resilient material. The separating foil is positioned between the second electrode layer and the moisture-absorber. Spacer structures such as dots are applied on the separating foil between the foil and the cover.
    Type: Grant
    Filed: June 15, 2011
    Date of Patent: July 12, 2016
    Assignee: Koninklijke Philips Electronics N.V.
    Inventors: Herbert Friedrich Boerner, Rainald Manfred Gierth, Stefan Peter Grabowski, Petrus Cornelis Paulus Bouten, Peter Van de Weijer
  • Publication number: 20160146634
    Abstract: A rotary angle sensor used to determine a relative angular position as compared to a reference position, comprising a housing (1), at least one rotor (3, 4) that is rotatably mounted inside said housing (1), one circuit board (2) containing electrical and/or electronic components as well as one or multiple stators corresponding to the number of used rotors (3, 4). The rotary angle sensor is supposed to be improved in such a manner that a particularly precise alignment of the first rotor (3) in relation to the stator is ensured and that it is inexpensive to manufacture. This is achieved by a first rotor (3) that is interlocked with the housing (1) without any play while a pre-loaded spring washer (14) is positioned on the latching arms (11).
    Type: Application
    Filed: June 29, 2013
    Publication date: May 26, 2016
    Inventors: Thomas Elpermann, Stefan Peters